Makhzoumi Mohamad

10% owner at Korro Bio, Inc. · on record since Nov 7, 2023
10% owner at MBX Biosciences, Inc. · on record since Sep 17, 2024
10% owner at SpyGlass Pharma, Inc. · on record since Feb 11, 2026
10% owner at Eargo, Inc. · on record since Oct 22, 2020
10% owner at OnKure Therapeutics, Inc. · on record since Apr 15, 2021
10% owner at Regulus Therapeutics Inc. · on record since Jul 31, 2017
10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
10% owner at GENOCEA BIOSCIENCES, INC. · on record since Jan 23, 2018
Director at SYNLOGIC, INC. · on record since Aug 14, 2026
10% owner at SYNLOGIC, INC. · on record since Aug 14, 2026
10% owner at Achaogen, Inc. · on record since Jun 29, 2018
10% owner at AVEO PHARMACEUTICALS, INC. · on record since Jun 28, 2018
10% owner at ARDELYX, INC. · on record since Jul 17, 2018
10% owner at Marker Therapeutics, Inc. · on record since Oct 18, 2018
10% owner at Tempest Therapeutics, Inc. · on record since Dec 11, 2018
10% owner at Nightstar Therapeutics plc · on record since Jan 2, 2019
10% owner at Trevi Therapeutics, Inc. · on record since May 13, 2019
10% owner at Mirum Pharmaceuticals, Inc. · on record since Jul 24, 2019
10% owner at · on record since Jul 30, 2021
10% owner at · on record since Jan 29, 2020
10% owner at · on record since Jun 25, 2020
10% owner at · on record since Jul 28, 2020
10% owner at · on record since Jul 23, 2020
10% owner at · on record since Sep 22, 2020
10% owner at · on record since Jul 16, 2020
10% owner at · on record since Dec 11, 2020
Director at · on record since Jul 29, 2021
10% owner at · on record since Jul 29, 2021
Former 10% Owner at · on record since Mar 16, 2021
10% owner at · on record since Mar 16, 2021
10% owner at · on record since Jan 4, 2021
Director at · on record since Jun 30, 2021
10% owner at · on record since Jun 30, 2021
10% owner at · on record since Jun 30, 2021
10% owner at · on record since Oct 4, 2021
10% owner at · on record since Feb 9, 2022
10% owner at · on record since Jun 15, 2022

Insider trading activity of Makhzoumi Mohamad

Transactions on record: 293; since Jun 28, 2018

Open-market buys: 45; $222M

Open-market sells: 13; $18.4M

Companies traded: 23; last filing Mar 12, 2026

Figures computed from official regulatory filings — .

Companies where Makhzoumi Mohamad has traded

3 tx · $6M · Mar 12, 2026
15 tx · $40M · Feb 13, 2026
13 tx · $15M · Feb 11, 2026
88 tx · $372.8M · Oct 6, 2025
5 tx · $8M · Sep 17, 2024
1 tx · $1M · Jul 19, 2023
8 tx · $6.8M · Jun 15, 2023
7 tx · $5M · Dec 22, 2022
8 tx · $10M · Dec 2, 2022
8 tx · $17.1M · Nov 18, 2022
27 tx · $18.9M · Oct 21, 2022
7 tx · $23.3M · May 26, 2022
46 tx · $77.2M · May 4, 2022
8 tx · $10.5M · Dec 27, 2021

Track record of Makhzoumi Mohamad

Statistical track record

Free account

Open-market buys: 58

Last buy: Mar 10, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Makhzoumi Mohamad

Co-insiders of Makhzoumi Mohamad

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Korro Bio, Inc.Listing on record	Mar 12, 2026	Buy	207,100	11.11 USD	$2.3M	conv 35Cluster	SEC
Korro Bio, Inc.Listing on record	Mar 12, 2026	BuyD (derivative)	242,945	11.11 USD	$2.7M	Cluster	SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-1,851,852	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	Other	1,851,852	1.37 USD	$2.5M		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-954,990	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-737,962	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Buy	937,500	16.00 USD	$15M	conv 56ClusterFirst in 12mo	SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	402,273	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	737,962	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-402,273	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	954,990	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	-2,384,873	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Exercise	189,195	0.01 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	ExerciseD (derivative)	-607,536	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-125,000	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Exercise	189,195	0.01 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	-1,159,683	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Exercise	607,536	0.01 USD	$6.1K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	-280	6.75 USD	$1.9K		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Korro Bio, Inc.Listing on record	Mar 12, 2026	Buy	207,100	11.11 USD	$2.3M	conv 35Cluster	SEC
Korro Bio, Inc.Listing on record	Mar 12, 2026	BuyD (derivative)	242,945	11.11 USD	$2.7M	Cluster	SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-1,851,852	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	Other	1,851,852	1.37 USD	$2.5M		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-954,990	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-737,962	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Buy	937,500	16.00 USD	$15M	conv 56ClusterFirst in 12mo	SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	402,273	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	737,962	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-402,273	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	954,990	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	Other	1,619,240	—	n/a (No price was disclosed in the filing)		SEC
SpyGlass Pharma, Inc.Listing unverified	Feb 11, 2026	OtherD (derivative)	-1,370,168	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	-2,384,873	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Exercise	189,195	0.01 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	ExerciseD (derivative)	-607,536	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	OtherD (derivative)	-125,000	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Exercise	189,195	0.01 USD	$1.9K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	-1,159,683	—	n/a (No price was disclosed in the filing)		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Exercise	607,536	0.01 USD	$6.1K		SEC
NeueHealth, Inc.Listing unverified	Oct 6, 2025	Other	-280	6.75 USD	$1.9K		SEC